This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

As of last week, Chris Klomp is in charge of the Center for Medicare. Unlike predecessors, he’s not a policy wonk. Klomp was ...

Merck will grow its U.S. manufacturing footprint with a $1 billion plant, making it the latest drugmaker to invest in the U.S ...

Some telehealth companies that offered compounded GLP-1s have disappeared altogether. Others are pursuing strategies that ...

There is common ground. Most adults favor: Preventing chronic diseases (Republicans 86%, Democrats 91%) Protecting against ...

Stealth BioTherapeutics had expected the FDA to respond on Tuesday to its marketing application for elamipretide to treat ...

Novo is expanding its direct-to-consumer efforts around its obesity drug Wegovy, partnering with telehealth companies ...

If the law is struck down or any ambiguity left surrounding its validity, coverage of and access to preventive care like PrEP ...

With a May 24 deadline looming, Kennedy's MAHA commission has held just one full meeting on its goal of reducing childhood ...

For the second consecutive year, the pharma industry saw its reputation dip among patient advocacy groups, largely due to ...

FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.

A new study seems to confirm that a single dose of the vaccine used to prevent HPV infection is just as effective as two — ...